eprintid: 6140
rev_number: 6
eprint_status: archive
userid: 1558
dir: disk0/00/00/61/40
datestamp: 2021-03-01 15:28:02
lastmod: 2021-03-01 15:28:02
status_changed: 2021-03-01 15:28:02
type: article
metadata_visibility: show
creators_name: Supandi Supandi, Supandi
creators_id: supandi@uhamka.ac.id
contributors_type: http://www.loc.gov/loc.terms/relators/AUT
contributors_type: http://www.loc.gov/loc.terms/relators/AUT
contributors_type: http://www.loc.gov/loc.terms/relators/AUT
contributors_name: Dwita, Lusi Putri
contributors_name: Supandi, Supandi
contributors_name: Yeni, Yeni
title: In Vitro Study of Kaempferia galanga L. Compound, δ- 3-Carene, Against 5-Lipoxygenase
ispublished: pub
subjects: Q1
divisions: 12
abstract: Kaempferia galanga has anti-inflammatory activity and worth developing as lipoxygenase inhibitors. The aim of this study was to determined δ-3-carene, one of the potential compounds of K. galanga, as a lipoxygenase inhibitor. The LOX-inhibitor activity was tested in-vitro. The result showed that the IC50 of δ-3-carene was 23.10 μM, which was less potential compare to zileuton (7.54 μM). The study showed that K. galanga contains possible active components that could be developed as 5-LOX-inhibitor.
publisher: Atlantis Press
full_text_status: public
publication: Advances in Health Sciences Research
volume: 33
pagerange: 443-444
refereed: TRUE
citation:   Supandi Supandi, Supandi   In Vitro Study of Kaempferia galanga L. Compound, δ- 3-Carene, Against 5-Lipoxygenase.  Advances in Health Sciences Research, 33.  pp. 443-444.      
document_url: http://repository.uhamka.ac.id/id/eprint/6140/1/prosiding%20UMY.pdf